Neogenomics (NEO) Other Gross PP&E Adjustments: 2011-2025
Historic Other Gross PP&E Adjustments for Neogenomics (NEO) over the last 14 years, with Sep 2025 value amounting to -$87.8 million.
- Neogenomics' Other Gross PP&E Adjustments rose 2.25% to -$87.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$88.1 million, marking a year-over-year increase of 39.70%. This contributed to the annual value of $200.7 million for FY2024, which is 28.76% up from last year.
- Neogenomics' Other Gross PP&E Adjustments amounted to -$87.8 million in Q3 2025, which was up 10.55% from -$98.1 million recorded in Q2 2025.
- Over the past 5 years, Neogenomics' Other Gross PP&E Adjustments peaked at $200.7 million during Q4 2024, and registered a low of -$127.3 million during Q1 2022.
- Over the past 3 years, Neogenomics' median Other Gross PP&E Adjustments value was -$98.1 million (recorded in 2025), while the average stood at -$50.8 million.
- Per our database at Business Quant, Neogenomics' Other Gross PP&E Adjustments tumbled by 129.22% in 2021 and then climbed by 28.76% in 2024.
- Quarterly analysis of 5 years shows Neogenomics' Other Gross PP&E Adjustments stood at $114.9 million in 2021, then grew by 17.98% to $135.5 million in 2022, then rose by 14.99% to $155.8 million in 2023, then climbed by 28.76% to $200.7 million in 2024, then grew by 2.25% to -$87.8 million in 2025.
- Its last three reported values are -$87.8 million in Q3 2025, -$98.1 million for Q2 2025, and -$102.8 million during Q1 2025.